WallStreetZenWallStreetZen

NASDAQ: UTHR
United Therapeutics Corp Stock Ownership - Who owns United Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have United Therapeutics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Paul A. MahonEVP GENERAL COUNSEL2026-02-191,467$478.92
$702.57kSell
Paul A. MahonEVP GENERAL COUNSEL2026-02-19775$472.76
$366.39kSell
Paul A. MahonEVP GENERAL COUNSEL2026-02-191,059$475.09
$503.12kSell
Paul A. MahonEVP GENERAL COUNSEL2026-02-19616$471.36
$290.36kSell
Paul A. MahonEVP GENERAL COUNSEL2026-02-198,300$146.03
$1.21MBuy
Paul A. MahonEVP GENERAL COUNSEL2026-02-192,100$478.15
$1.00MSell
Paul A. MahonEVP GENERAL COUNSEL2026-02-19881$475.89
$419.26kSell
Paul A. MahonEVP GENERAL COUNSEL2026-02-19288$473.23
$136.29kSell
Paul A. MahonEVP GENERAL COUNSEL2026-02-191,114$477.10
$531.48kSell
Michael BenkowitzPRESIDENT AND COO2026-02-177,875$480.75
$3.79MSell

1 of 94

UTHR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when UTHR insiders and whales buy or sell their stock.

UTHR Shareholders

What type of owners hold United Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lilly Co Eli12.20%5,251,394$2.49BInsider
Blackrock Inc12.01%5,170,766$2.45BInstitution
Vanguard Group Inc9.70%4,176,016$1.98BInstitution
Avoro Capital Advisors LLC6.05%2,606,060$1.23BInstitution
Wellington Management Group LLP5.67%2,441,492$1.16BInstitution
Renaissance Technologies LLC4.43%1,909,259$903.88MInstitution
State Street Corp4.28%1,842,411$872.23MInstitution
Aqr Capital Management LLC2.98%1,281,699$606.78MInstitution
Geode Capital Management LLC2.77%1,193,064$564.82MInstitution
Martine A. Rothblatt1.95%838,072$396.76MInsider

1 of 3

UTHR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
UTHR86.91%13.09%Net SellingNet Selling
INCY77.80%22.20%Net SellingNet Selling
RVMD91.20%8.80%Net SellingNet Selling
ROIV43.08%56.92%Net SellingNet Selling
MRNA76.86%22.49%Net BuyingNet Buying
View Top Biotech Stocks

United Therapeutics Stock Ownership FAQ

Who owns United Therapeutics?

United Therapeutics (NASDAQ: UTHR) is owned by 96.62% institutional shareholders, 14.55% United Therapeutics insiders, and 0.00% retail investors. Lilly Co Eli is the largest individual United Therapeutics shareholder, owning 5.25M shares representing 12.20% of the company. Lilly Co Eli's United Therapeutics shares are currently valued at $2.49B.

If you're new to stock investing, here's how to buy United Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.